search
Back to results

MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and Application (MEDUSA)

Primary Purpose

Migraine, Self-Assessment

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
N1-Headache App (by Curelator)
Sponsored by
Cumbria Partnership NHS Foundation Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Migraine focused on measuring migraine, patient diary

Eligibility Criteria

16 Years - 120 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: • Primary care patients diagnosed with or attending their GP practice ('coded for') migraine in the last 5 years. This may therefore be newly diagnosed patients or patients with long-standing migraine who attended their GP practice about their condition. Patients aged ≥ 16 years Mental capacity to give consent and not using an interpreter for GP consultations (ie competent in English and capacity to complete postal survey) Part 2 only: Completion of complete part 1 survey, including indication that patient still has ongoing migraine issues. Access to email, internet and Apple or Android technology (ie smartphone, tablet or computer) Exclusion Criteria: • Under the age of 16 years Unable to fully understand the consent process and provide informed consent due to either language barriers or mental capacity The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise their capacity to complete the survey. Examples would be current severe ill health episode.

Sites / Locations

  • Research & Development Department

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

N1-Headache App

Arm Description

All participants used the N1-HEadache App, a digital migraine diary that allows identification of triggers/protectors for migraine (as well as monitoring of medication use)

Outcomes

Primary Outcome Measures

patient interest in N1 Headache App
percentage of survey responders who indicate they are willing to trial the N1 Headache App
user compliance for N1 Headache App
percentage of participants who consent to using the App who comply with daily use in 90 day trial period

Secondary Outcome Measures

previous use of digital diary Apps for migraine
what percentage of responders has previously used a digital diary App for migraine
usefulness of N1 Headache App: percentage patients who identify a migraine trigger
What percentage of patients who use the N1 Headache App often enough do identify a migraine trigger when a report is generated
Health Confidence and digital diary App
Does use of digital diary App for migraine affect patients' HEalth Confidence Score (Degree of agreeableness with statement 'I know enough about my migraine health', answers being 'disagree', 'neutral', 'agree' and 'strongly agree'

Full Information

First Posted
July 14, 2023
Last Updated
July 27, 2023
Sponsor
Cumbria Partnership NHS Foundation Trust
search

1. Study Identification

Unique Protocol Identification Number
NCT05979285
Brief Title
MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and Application
Acronym
MEDUSA
Official Title
Evaluation of Patient Experiences of Migraine Management and Feasibility of a Digital Headache Diary in Primary Care Setting: a Prospective Cohort Survey and Evaluative Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
October 15, 2020 (Actual)
Primary Completion Date
July 31, 2021 (Actual)
Study Completion Date
December 20, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Cumbria Partnership NHS Foundation Trust

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Migraine is a very common condition characterised by frequent severe headaches that are very debilitating. Although the frequency and severity does reduce as patient's age, particularly above the age of 70, in younger and working age people this condition has a significant impact on people's lives. Patients with migraine are typically diagnosed and managed in primary care, but can also be treated by neurologists. Recently, NHS England has published guidance for clinical staff to optimise patient management: reduce admissions to hospital for migraine and improve the setting in which patients are seen. One recommendation is the increased use of headache diaries by patients. These may help patients and doctors to improve migraine diagnosis and its treatment, for example by identifying if there are triggers for getting a migraine attack. With technological advancements, there are now computer/phone applications (Apps) that can be used instead of a paper diary. The Curelator N1 Headache App is one of such migraine specific Apps. In this study, the investigators aim to evaluate if primary care migraine patients are open to using a digital headache diary App, and how compliant users of the App will be. The investigators also aim to assess patient feedback on the use of the N1 Headache App, and if its use aids them in the management of their migraine.
Detailed Description
Headaches are one of the most common ailments, and the headache disorder migraine is the second leading cause of years lived with disability. Some figures for the UK illustrate the extent of the issue: approximately 10 million people aged 15 - 69 live with migraine , and 3 million workdays are lost every year in to migraine-related absenteeism alone, at a cost of almost £4.4 billion. In the UK, the annual primary care consultation rate for headache is 4.4 per 100 registered patients, of whom 4% are referred to secondary care for further assessment. Headache and migraine is the top self-reported chronic condition amongst primary care patients. Management, including self-management, of migraine appears to be sub-optimal. Compliance with prophylactic therapy is poor with a limited number of patients using preventive treatment, even though many do try prophylactic medicines at some stage. After diagnosis there is often also a delay before preventive treatment is attempted, and commonly only tried once. The issues related to migraine are worsening as reported by NHS England and in the national media : "NHS England has announced plans aimed at preventing up to 16,500 emergency hospital admissions for headaches and migraines each year. Greater use of headache diaries, where patients record their symptoms, and faster access to specialist advice for family doctors are among the measures intended to reduce the pressure on frontline services." Headache diaries can be paper-based or electronic (Applications or Apps), and prospective or retrospective. Retrospective diaries are prone to under and overestimation by patients, and 'gaming' - completing e.g. a month worth of data at the end of that month - is a potential issue with prospective paper-based headache diaries. Electronic diaries may therefore offer a viable alternative to paper diaries. Numerous migraine diary Apps have been developed in the last decade, and some of them were found not user-friendly or did not measure clinically relevant outcomes. A more recent review on the topic of digital headache diaries concluded that patient and clinically relevant outcome measures for many were Apps were lacking. It is, however, recognised that headache diaries can aid patients and clinicians to track the course of a headache disorder, help to identify triggers and inform treatment plans. The usefulness of health Apps can be measured with a validated Mobile App Rating Scale. Study aims and hypothesis To assess if a digital headache diary App (Curelator N1 Headache) is an acceptable tool to monitor migraine in a cohort of primary care patients diagnosed with/coded for migraine by their GP practice. Furthermore, to determine the compliance rates achieved by users of the N1 Headache App.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Migraine, Self-Assessment
Keywords
migraine, patient diary

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Prospective cohort study
Masking
None (Open Label)
Allocation
N/A
Enrollment
887 (Actual)

8. Arms, Groups, and Interventions

Arm Title
N1-Headache App
Arm Type
Experimental
Arm Description
All participants used the N1-HEadache App, a digital migraine diary that allows identification of triggers/protectors for migraine (as well as monitoring of medication use)
Intervention Type
Device
Intervention Name(s)
N1-Headache App (by Curelator)
Intervention Description
Digital application allowing patients to monitor their migraines, and to identify triggers and/or protectors for their migraines.
Primary Outcome Measure Information:
Title
patient interest in N1 Headache App
Description
percentage of survey responders who indicate they are willing to trial the N1 Headache App
Time Frame
30 days
Title
user compliance for N1 Headache App
Description
percentage of participants who consent to using the App who comply with daily use in 90 day trial period
Time Frame
90 days
Secondary Outcome Measure Information:
Title
previous use of digital diary Apps for migraine
Description
what percentage of responders has previously used a digital diary App for migraine
Time Frame
30 days
Title
usefulness of N1 Headache App: percentage patients who identify a migraine trigger
Description
What percentage of patients who use the N1 Headache App often enough do identify a migraine trigger when a report is generated
Time Frame
90 days
Title
Health Confidence and digital diary App
Description
Does use of digital diary App for migraine affect patients' HEalth Confidence Score (Degree of agreeableness with statement 'I know enough about my migraine health', answers being 'disagree', 'neutral', 'agree' and 'strongly agree'
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
120 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: • Primary care patients diagnosed with or attending their GP practice ('coded for') migraine in the last 5 years. This may therefore be newly diagnosed patients or patients with long-standing migraine who attended their GP practice about their condition. Patients aged ≥ 16 years Mental capacity to give consent and not using an interpreter for GP consultations (ie competent in English and capacity to complete postal survey) Part 2 only: Completion of complete part 1 survey, including indication that patient still has ongoing migraine issues. Access to email, internet and Apple or Android technology (ie smartphone, tablet or computer) Exclusion Criteria: • Under the age of 16 years Unable to fully understand the consent process and provide informed consent due to either language barriers or mental capacity The patient has concurrent (medical) conditions that in the opinion of the investigator may compromise their capacity to complete the survey. Examples would be current severe ill health episode.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stacey J Fisher, MD
Organizational Affiliation
substantive employee
Official's Role
Principal Investigator
Facility Information:
Facility Name
Research & Development Department
City
Carlisle
State/Province
Cumbria
ZIP/Postal Code
CA1 3SX
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
35364371
Citation
Jonker L, Fitzgerald L, Vanderpol J, Fisher S. Digital diary App use for migraine in primary care: Prospective cohort study. Clin Neurol Neurosurg. 2022 Mar 25;216:107225. doi: 10.1016/j.clineuro.2022.107225. Online ahead of print.
Results Reference
result

Learn more about this trial

MEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and Application

We'll reach out to this number within 24 hrs